Shen A - Search Results

1

A systematic review of sorafenib in Child-Pugh A patients with unresectable hepatocellular carcinoma.

Shen A, Tang C, Wang Y, Chen Y, Yan X, Zhang C, Liu R, Wei X, Zhu Y, Zhang H, Wu Z. Shen A, et al. J Clin Gastroenterol. 2013 Nov-Dec;47(10):871-80. doi: 10.1097/MCG.0b013e3182a87cfd. J Clin Gastroenterol. 2013. PMID: 24100749 Review.

2

Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.

Shen A, Zhang H, Tang C, Chen Y, Wang Y, Zhang C, Wu Z. Shen A, et al. J Gastroenterol Hepatol. 2013 May;28(5):793-800. doi: 10.1111/jgh.12162. J Gastroenterol Hepatol. 2013. PMID: 23432154

3

Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.

Fu Y, Wei X, Tang C, Li J, Liu R, Shen A, Wu Z. Fu Y, et al. Among authors: shen a. Oncol Lett. 2013 Dec;6(6):1811-1815. doi: 10.3892/ol.2013.1638. Epub 2013 Oct 21. Oncol Lett. 2013. PMID: 24260081 Free PMC article.

4

p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.

Shen A, Liu S, Yu W, Deng H, Li Q. Shen A, et al. J Gastroenterol Hepatol. 2015 Nov;30(11):1651-6. doi: 10.1111/jgh.13009. J Gastroenterol Hepatol. 2015. PMID: 25968838

5

Everolimus in de novo liver transplant recipients: a systematic review.

Tang CY, Shen A, Wei XF, Li QD, Liu R, Deng HJ, Wu YZ, Wu ZJ. Tang CY, et al. Among authors: shen a. Hepatobiliary Pancreat Dis Int. 2015 Oct;14(5):461-9. doi: 10.1016/s1499-3872(15)60419-2. Hepatobiliary Pancreat Dis Int. 2015. PMID: 26459721 Review.

6

IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.

Liu R, Tang C, Shen A, Luo H, Wei X, Zheng D, Sun C, Li Z, Zhu D, Li T, Wu Z. Liu R, et al. Among authors: shen a. Oncotarget. 2016 Dec 20;7(51):85079-85096. doi: 10.18632/oncotarget.13196. Oncotarget. 2016. PMID: 27835881 Free PMC article.

7

IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling.

Pu XY, Zheng DF, Shen A, Gu HT, Wei XF, Mou T, Zhang JB, Liu R. Pu XY, et al. Among authors: shen a. Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):408-415. doi: 10.1016/j.hbpd.2018.08.009. Epub 2018 Aug 29. Hepatobiliary Pancreat Dis Int. 2018. PMID: 30201411

8

Role of miR-148a in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway via Targeting CaMKIIα in Vivo and in Vitro.

Zheng D, Li Z, Wei X, Liu R, Shen A, He D, Tang C, Wu Z. Zheng D, et al. Among authors: shen a. Cell Physiol Biochem. 2018;49(5):2060-2072. doi: 10.1159/000493716. Epub 2018 Sep 21. Cell Physiol Biochem. 2018. Retraction in: Cell Physiol Biochem. 2022 Oct 31;56(5):610. doi: 10.33594/000000582. PMID: 30244246 Free article. Retracted.

9

Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.

Shen A, Liu M, Zheng D, Chen Q, Wu Z. Shen A, et al. Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):142-154. doi: 10.1016/j.clinre.2019.06.012. Epub 2019 Jul 11. Clin Res Hepatol Gastroenterol. 2020. PMID: 31303533

10

MicroRNA-24-3p alleviates hepatic ischemia and reperfusion injury in mice through the repression of STING signaling.

Shen A, Zheng D, Luo Y, Mou T, Chen Q, Huang Z, Wu Z. Shen A, et al. Biochem Biophys Res Commun. 2020 Jan 29;522(1):47-52. doi: 10.1016/j.bbrc.2019.10.182. Epub 2019 Nov 14. Biochem Biophys Res Commun. 2020. PMID: 31735332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,867 results

Search Page